Study Finds Exenatide Not Beneficial for Parkinson Disease

FRIDAY, Feb. 7, 2025-- The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity, according to a study published online Feb. 4 in The Lancet.Nirosen Vijiaratnam, M.D., from the...